{
    "2019-12-18": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Danaher wins conditional EU okay for $21 billion biopharma buy",
                "features": {
                    "keywords": [
                        "Danaher",
                        "conditional",
                        "EU",
                        "okay",
                        "biopharma",
                        "buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biopharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Danaher Announces Final Results Of Envista Exchange Offer",
                "features": {
                    "keywords": [
                        "Danaher",
                        "Announces",
                        "Final",
                        "Results",
                        "Envista",
                        "Exchange",
                        "Offer"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}